Surgical perspective in neoadjuvant chemoimmunotherapy for stage II–III non‐small cell lung cancer

Surgical perspective in neoadjuvant chemoimmunotherapy for stage II–III non‐small cell lung cancer

Abstract Background There are many studies on neoadjuvant immunotherapy for locally advanced non‐small cell lung cancer (NSCLC) patients. Expert consensus recommends neoadjuvant immunotherapy for patients with resectable stage IB–IIIA NSCLC. However, there are few clinical studies or cases to verify...

Full description

Bibliographic Details
Main Authors: Tao Hong, Teng Sun, Miao Zhang, Xinlong Liu, Yanliang Yuan, Ponnie Robertlee Dolo, Bi Chen, Hao Zhang
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Thoracic Cancer
Subjects:
neoadjuvant chemoimmunotherapy
neoadjuvant treatment
non‐small cell lung cancer
surgical resection
Online Access:https://doi.org/10.1111/1759-7714.14127

Internet

https://doi.org/10.1111/1759-7714.14127

Similar Items